Wave Life Sciences WVE
NASDAQ WVE
$4.84 +0.14 (+2.87%)
As of: Sep 4, 2026 · 3:18 PM EDT

Wave Life Sciences (WVE) Other Non-Current Liabilities (2014 - 2023)

Wave Life Sciences' (WVE) quarterly Other Non-Current Liabilities came in at $190000.0 in Q2 2023, little changed on a QoQ basis from $190000.0 in Q1 2023.

Analysis

Wave Life Sciences (WVE) Other Non-Current Liabilities (2014 - 2023) Analysis & Trends

Wave Life Sciences (WVE) has 10 years of Other Non-Current Liabilities data on file, last reported at $190000.0 in Q2 2023.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to $190000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $190000.0 (changed N/A YoY) and the FY2022 annual result came in at $190000.0, changed N/A from the prior year.
  • Other Non-Current Liabilities held at $190000.0 in Q2 2023, from $190000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.0 million in Q1 2019 to a low of $190000.0 in Q4 2022.
  • A 5-year average of $1.0 million and a median of $1.0 million in 2021 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 113.27% — and 2023, when it sank 78.11%.
  • Tracing WVE's Other Non-Current Liabilities over 5 years: stood at $1.7 million in 2019, then sank by 72.46% to $474000.0 in 2020, then surged by 113.92% to $1.0 million in 2021, then slumped by 81.26% to $190000.0 in 2022, then changed by 0.0% to $190000.0 in 2023.
  • The last three Other Non-Current Liabilities figures came in at $190000.0 (Q2 2023), $190000.0 (Q1 2023), and $190000.0 (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Wave Life Sciences 986.38 Mn 618.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 190,000.00
Mar 31, 2023 190,000.00
Dec 31, 2022 190,000.00
Mar 31, 2022 868,000.00
Sep 30, 2021 1.01 Mn
Jun 30, 2021 339,000.00
Mar 31, 2021 407,000.00
Dec 31, 2020 474,000.00
Sep 30, 2020 1.42 Mn
Jun 30, 2020 1.52 Mn
Mar 31, 2020 1.62 Mn
Dec 31, 2019 1.72 Mn
Sep 30, 2019 1.79 Mn
Jun 30, 2019 1.90 Mn
Mar 31, 2019 2.04 Mn
Dec 31, 2018 2.14 Mn
Sep 30, 2018 1.50 Mn
Jun 30, 2018 1.53 Mn
Mar 31, 2018 1.61 Mn
Dec 31, 2017 1.62 Mn